Description

• Include: 120 videos, size: 65.2 GB
•  Target Audience: gastroenterologists, surgeons, clinical pathologists and radiologists

Topics:

• AASLD ASGE Endoscopy Course Part 1.mp4
• AASLD ASGE Endoscopy Course Part 2.mp4
• AASLD ASGE Endoscopy Course Part 3.mp4
• AASLD ASGE Endoscopy Course Part 4.mp4
• AASLD ILTS Transplant Course Part 1.mp4
• AASLD ILTS Transplant Course Part 2.mp4
• AASLD ILTS Transplant Course Part 3.mp4
• AASLD ILTS Transplant Course Part 4.mp4
• AASLD Japanese Joint Symposium Cutting Edge – Approach to Diagnostics and Treatments in Chronic Liver Disease.mp4
• AASLD NASPGHAN Pediatric Symposium Part 1 Epidemic of Severe Acute Hepatitis in Children – Epidemiology, Breakthroughs and Future Response.mp4
• AASLD NASPGHAN Pediatric Symposium Part 2 Hepatology Meet Hematology – Can One Live Without the Other.mp4
• AASLD Practice Guidelines Workshop What’s New.mp4
• Academic Debate.mp4
• ACLF Better Characterize and Treatment.mp4
• Advances in the Management of Primary Biliary Cholangitis, Primary Sclerosing Cholangitis and Cholangiocarcinoma A Global Perspective.mp4
• Alcohol All Things Considered – Biomarkers to Developing a Clinical Research Program in AlcoholAssociated Liver Disease.mp4
• Alcohol Related Liver Disease Epidemiology, Mortality, and Treatment.mp4
• Alcohol-associated Liver Disease Debrief.mp4
• Alcohol-Associated Liver Disease Patient Programming.mp4
• Alcohol-Associated Liver Disease SIG Early Liver Transplantation for Severe Alcohol-Associated Hepatitis The Keys for Selection, Prognostication, and Monitoring.mp4
• Alcohol-Associated Liver Disease_ Experimental Approaches to Decipher Pathogenesis.mp4
• APP-Led Care & Quality Initiatives.mp4
• Ascites, AKI, and Albumin.mp4
• Autoimmune PBC PSC Patient Programming The Role of the Microbiome in Autoimmune Liver Disease.mp4
• Basic Research Workshop Humanized Models – Tools To Advance Liver Disease Research 1.mp4
• Basic Research Workshop Humanized Models – Tools To Advance Liver Disease Research 2.mp4
• Basic Science Debrief.mp4
• Basic Science Plenary #1.mp4
• Basic Science Symposium Bile Acids at the Cross-Road of the Gut-Liver and Brain-Liver Axes Part 1.mp4
• Basic Science Symposium Bile Acids at the Cross-Road of the Gut-Liver and Brain-Liver Axes Part 2.mp4
• Basic Science Symposium Bile Acids at the Cross-Road of the Gut-Liver and Brain-Liver Axes Part 3.mp4
• Basic Science Symposium Bile Acids at the Cross-Road of the Gut-Liver and Brain-Liver Axes Part 4.mp4
• Breaking the Chains of Cholestatic Liver Injury Advancements and Promising Treatment Strategies.mp4
• Career Development Workshop.mp4
• Cholestatic and Autoimmune Liver Diseases SIG The Gut-Liver Axis as Therapeutic Target in Cholestatic Liver Disease.mp4
• Cirrhosis And Portal Hypertension Parallel Session New Insights in Brain-Gut.mp4
• Clinical Plenary 1.mp4
• Clinical Plenary 2.mp4
• Clinical Practice SIG.mp4
• Community Conversation New 2023 WHO Hepatitis B Global Guidelines on Diagnosis, Treatment and Service Delivery.mp4
• Current Trends in Liver Transplants.mp4
• Decoding the Immunological Tango_ Unraveling the Complex Interplay Between Inflammation and Liver Disease.mp4
• Distinguished Awards and Awards & Honors Ceremony.mp4
• Don’t Be Scarred Basic Fibrosis Research.mp4
• Emerging Translational Approaches Targeting Cellulargeospatial Heterogeneity in Cholangiocarcinoma.mp4
• Epidemiology and Natural History of MASLD.mp4
• Evolving Impact of Hepatology Associates in Liver Care.mp4
• Evolving Treatment Paradigms in Hepatocellular Carcinoma.mp4
• Experimental Insights into MASLD and MASH.mp4
• Experimental MASLD – Clinical.mp4
• General Hepatology Update.mp4
• Genetic and Metabolic Disease Diagnosis, Outcomes, and Treatment.mp4
• Gut Microbiota-Liver Crosstalk.mp4
• Hans Popper State-of-the-Art Lecture Next Generation Human Liver Gene Therapy.mp4
• HBV Virology, Pathogenesis & Immunology.mp4
• HCC Debrief.mp4
• Health Disparities Solutions.mp4
• Healthy Lifestyle Wellness Nutrition Patient Programming.mp4
• Hepatitis B D Controversies in Diagnosis, Natural History and Treatment.mp4
• Hepatitis B New Therapies for HBV and HDV.mp4
• Hepatitis B Patient Programming.mp4
• Hepatitis B SIG Hepatitis B Optimizing Diagnosis and Management To Achieve Elimination.mp4
• Hepatitis C Innovations to Advance Elimination.mp4
• Hepatitis C Patient Programming White House Hepatitis C Elimination Plan What It Means for You and Your Community.mp4
• Hepatitis C SIG.mp4
• Hepatitis Elimination A Global Vision.mp4
• Hepatology Associates Course Part 1.mp4
• Hepatology Associates Course Part 2.mp4
• Hepatotoxicity SIG.mp4
• Hyman J. Zimmerman Hepatotoxicity State-of-the Art Lecture Acetaminophen Detection and Treatment in 2023.mp4
• Implementation Heroes Masters of the Art of Care Delivery in Hepatology.mp4
• Insights into Basic Mechanisms of Hepatocarcinogenesis.mp4
• Leon Schiff State-of-the-Art Lecture Personalized Approach to HCC.mp4
• Liver Cancer Patient Programming.mp4
• Liver Cancer SIG Role of Systemic Therapy From Early to Advanced Stages of HCC.mp4
• Liver Cell Biology in Hepatic Disease SIG Spatial Cellular Interactions and Functions in Liver Health and Disease.mp4
• Liver Fibrosis SIG Artificial Intelligence for the Diagnosis and Treatment of Liver Fibrosis.mp4
• Liver Transplantation and Surgery Special Interest Group (SIG).mp4
• MAFLD Patient Programming Patient-centered Management of Metabolic Dysfunctionassociated Steatotic Liver Disease (MASLD).mp4
• Managing Frailty Palliative Care Patient Programming.mp4
• MASLD – Approved Available Therapeutics.mp4
• NAFLD Global Variances and Therapeutic Approach.mp4
• Non-Invasive Tests for MASLD MASH Moving the Field Forward.mp4
• Novel Biomarkers in MASLD MASH.mp4
• Novel Diagnostics in Liver Cancer.mp4
• Novel Therapeutic Approaches for MASH.mp4
• Overcoming Inequalities in Health To Eliminate Hepatitis.mp4
• Patient Annual Forum and Keynote Address Patient Programming Stronger Together Patient-Provider Engagement in Liver.mp4
• Patient Centered Outcomes in Liver Disease Care.mp4
• Patient – Provider Communication Patient Programming.mp4
• Pediatric and Rare Diseases Patient Programming.mp4
• Pediatric Hepatology – Basic Science.mp4
• Pediatric Hepatology – Clinical.mp4
• Pediatric Liver Disorders SIG and NAFLD SIG Part 2.mp4
• Pediatric Liver Disorders SIG and Nonalcoholic Fatty Liver Disease (NAFLD) SIG Part 1.mp4
• Portal Hypertension Varices and Bleeding.mp4
• Portal Hypertension Clinical and Experimental SIG and Acute on Chronic Liver Failure (ACLF) SIG 1.mp4
• Portal Hypertension Clinical and Experimental SIG and Acute on Chronic Liver Failure (ACLF) SIG 2.mp4
• Postgraduate Course Cirrhosis as a Multisystem Disorder Part 1.mp4
• Postgraduate Course Cirrhosis as a Multisystem Disorder Part 2.mp4
• Postgraduate Course Cirrhosis as a Multisystem Disorder Part 3.mp4
• President’s Welcome.mp4
• President’s Choice State of the Art Lecture Digitized Medicine.mp
• Public Health Healthcare Delivery SIG Applied Health Informatics in Action.mp4
• Steatotic Liver Disease Nomenclature Implementation.mp4
• Surgery and Liver Transplantation Workshop Part 1.mp4
• Surgery and Liver Transplantation Workshop Part 2.mp4
• Targeting Genomics for Liver Disease Prognostics and Theraputics.mp4
• The Debrief 2023 Liver Transplantation.mp4
• The Editors’ Cut Clinical Studies.mp4
• The Editor’s Cut Basic and Translational Studies.mp4
• The Gritty Ascent to Leadership for Women in GI Hepatology.mp4
• The Liver, the Heart and the Vascular System.mp4
• The Social Determinants of Liver Health.mp4
• Thomas E. Starzl Transplant Surgery State-of-the-Art Lecture Alcohol-Associated Liver Disease – Transplant Triumphs and Challenges.mp4
• Transplant Surgery Plenary.mp4
• Transplant Tracker Advances in Liver Transplant for Children and Adults.mp4
• Transplant Tracker Parallel Session Liver Transplant Outcomes.mp4
• Vascular Liver Disease From Bench to Bedside.mp4
• Why Are You So Toxic Mechanisms of Hepatotoxicity.mp4